Michael Berg
Director Técnico/Científico/I+D en TEARLAB CORPORATION .
Perfil
Michael Berg is currently the Head-Regulatory, Reimbursement & Clinical at TearLab Corporation, Inc. and the President at Hemocue, Inc. He completed his undergraduate degree at the University of Notre Dame.
Cargos activos de Michael Berg
Empresas | Cargo | Inicio |
---|---|---|
TEARLAB CORPORATION | Director Técnico/Científico/I+D | - |
Hemocue, Inc. | Presidente | 20/05/2010 |
Formación de Michael Berg.
University of Notre Dame | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
TearLab Corporation, Inc.
TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Southlake, TX. | Health Technology |
Hemocue, Inc. |
- Bolsa de valores
- Insiders
- Michael Berg